Shopping Cart
- Remove All
- Your shopping cart is currently empty
Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $290 | In Stock | |
5 mg | $723 | In Stock | |
10 mg | $986 | In Stock | |
25 mg | $1,490 | In Stock | |
50 mg | $1,970 | In Stock |
Description | Avizakimab (BOS161721) is a humanized lgG1 monoclonal antibody that targets and inhibits the biological activity of IL-21, with potential for the treatment of systemic lupus erythematosus (SLE). |
In vitro | In vitro, Avizakimab blocks IL-22 binding to IL-22R1 and inhibits downstream STAT3 phosphorylation[1]. |
Alias | BOS161721, BOS 161721 |
Cas No. | 2229685-51-0 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice./Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.